Sub-chronic administration of rimonabant causes loss of antidepressive activity and decreases doublecortin immunoreactivity in the mouse hippocampus

Neuroscience Letters

Volumn 467, Issue 2, 2009, Pages 111-116

  Lee, Seungjoo ^a   Kim, Dong Hyun ^a   Yoon, Sung Hwa ^b   Ryu, Jong Hoon ^a  

^a Kyung Hee University   (South Korea)

^b Ajou University   (South Korea)

Author keywords

Doublecortin; Forced swimming test; Neurogenesis; Rimonabant

Indexed keywords

BROMODEOXYCYTIDINE; DOUBLECORTIN; IMIPRAMINE; RIMONABANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BIOCHEMISTRY; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; IMMOBILIZATION; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-OBESITY AGENTS; BEHAVIOR, ANIMAL; BROMODEOXYURIDINE; CELL COUNT; DEPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED ICR; MICROTUBULE-ASSOCIATED PROTEINS; NEUROGENESIS; NEURONS; NEUROPEPTIDES; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; STRESS, PSYCHOLOGICAL;

EID: 70350574040     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.10.017     Document Type: Article

References (40)

1. Adam A.S., Wenger T., and Csillag A. The cannabinoid CB1 receptor antagonist rimonabant dose-dependently inhibits memory recall in the passive avoidance task in domestic chicks (Gallus domesticus). Brain Res. Bull. 76 (2008) 272-274
2. Aguado T., Romero E., Monory K., Palazuelos J., Sendtner M., Marsicano G., Lutz B., Guzman M., and Galve-Roperh I. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J. Biol. Chem. 282 (2007) 23892-23898
3. Brodkin J., and Moerschbaecher J.M. SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats. J. Pharmacol. Exp. Ther. 282 (1997) 1526-1532
4. Chevaleyre V., Takahashi K.A., and Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29 (2006) 37-76
5. Christensen R., Kristensen P.K., Bartels E.M., Bliddal H., and Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370 (2007) 1706-1713
6. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., and Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci. 63 (1998) PL113-117
7. Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., and Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12796-12801
8. Duman R.S. Synaptic plasticity and mood disorders. Mol. Psychiatry 7 Suppl. 1 (2002) S29-34
9. Eisch A.J., Cameron H.A., Encinas J.M., Meltzer L.A., Ming G.L., and Overstreet-Wadiche L.S. Adult neurogenesis, mental health, and mental illness: hope or hype?. J. Neurosci. 28 (2008) 11785-11791
10. Gage F.H. Mammalian neural stem cells. Science 287 (2000) 1433-1438
11. Hampson R.E., and Deadwyler S.A. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J. Neurosci. 20 (2000) 8932-8942
12. Jiang W., Zhang Y., Xiao L., Van Cleemput J., Ji S.P., Bai G., and Zhang X. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J. Clin. Invest. 115 (2005) 3104-3116
13. Kronenberg G., Reuter K., Steiner B., Brandt M.D., Jessberger S., Yamaguchi M., and Kempermann G. Subpopulations of proliferating cells of the adult hippocampus respond differently to physiologic neurogenic stimuli. J. Comp. Neurol. 467 (2003) 455-463
14. Kunos G., Osei-Hyiaman D., Liu J., Godlewski G., and Batkai S. Endocannabinoids and the control of energy homeostasis. J. Biol. Chem. 283 (2008) 33021-33025
15. Li Y.F., and Luo Z.P. Depression: damage of neurons and down-regulation of neurogenesis. Yao Xue Xue Bao 39 (2004) 949-953
16. Li Y.F., Zhang Y.Z., Liu Y.Q., Wang H.L., Yuan L., and Luo Z.P. Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice. Acta Pharmacol. Sin. 25 (2004) 1408-1412
17. Malberg J.E., and Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28 (2003) 1562-1571
18. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20 (2000) 9104-9110
19. Mallet P.E., and Beninger R.J. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology (Berl) 140 (1998) 11-19
20. Mancini M.C., and Halpern A. Investigational therapies in the treatment of obesity. Exp. Opin. Investig. Drugs 15 (2006) 897-915
21. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
22. Crandall J., Sakai Y., Zhang J., Koul O., Mineur Y., Crusio W.E., and McCaffery P. 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci U S A 101 (2004) 5111-5116
23. Onaivi E.S. An endocannabinoid hypothesis of drug reward and drug addiction. Ann. N.Y. Acad. Sci. 1139 (2008) 412-421
24. K.B.J. Franklin, G. Paxinos, The Mouse brain in stereotaxic coordinates (2nd ed.), Academic Press, San Diego, 2001.
25. Perera T.D., Park S., and Nemirovskaya Y. Cognitive role of neurogenesis in depression and antidepressant treatment. Neuroscientist 14 (2008) 326-338
26. Plumpe T., Ehninger D., Steiner B., Klempin F., Jessberger S., Brandt M., Romer B., Rodriguez G.R., Kronenberg G., and Kempermann G. Variability of doublecortin-associated dendrite maturation in adult hippocampal neurogenesis is independent of the regulation of precursor cell proliferation. BMC Neurosci. 7 (2006) 77
27. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327-336
28. Sairanen M., Lucas G., Ernfors P., Castren M., and Castren E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 25 (2005) 1089-1094
29. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
30. Santoso A., Kaiser A., and Winter Y. Individually dosed oral drug administration to socially-living transponder-tagged mice by a water dispenser under RFID control. J. Neurosci. Methods 153 (2006) 208-213
31. Sommi R.W., Crismon M.L., and Bowden C.L. Fluoxetine: a serotonin-specific, second-generation antidepressant. Pharmacotherapy 7 (1987) 1-15
32. Soyka M. Rimonabant and depression. Pharmacopsychiatry 41 (2008) 204-205
33. Taupin P., and Gage F.H. Adult neurogenesis and neural stem cells of the central nervous system in mammals. J. Neurosci. Res. 69 (2002) 745-749
34. Thakker-Varia S., Krol J.J., Nettleton J., Bilimoria P.M., Bangasser D.A., Shors T.J., Black I.B., and Alder J. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J. Neurosci. 27 (2007) 12156-12167
35. Tzavara E.T., Davis R.J., Perry K.W., Li X., Salhoff C., Bymaster F.P., Witkin J.M., and Nomikos G.G. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br. J. Pharmacol. 138 (2003) 544-553
36. Van Gaal L.F., Rissanen A.M., Scheen A.J., Ziegler O., and Rossner S. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365 (2005) 1389-1397
37. Walker J.M., Huang S.M., Strangman N.M., Tsou K., and Sanudo-Pena M.C. Pain modulation by release of the endogenous cannabinoid anandamide. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 12198-12203
38. Xu H., Chen Z., He J., Haimanot S., Li X., Dyck L., and Li X.M. Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus 16 (2006) 551-559
39. Zhao B., Zhong M., and Jin K. Neurogenesis and neurodegenerative diseases in human. Panminerva Med. 50 (2008) 55-64
40. Zhao C., Deng W., and Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 132 (2008) 645-660